Skip to main content
Loading market data...
ETF NYSE Arca USD

Harbor Human Capital Factor US Small Cap ETF HAPS

Issuer: Harbor SEC registrant: Harbor ETF Trust Equity · US
Last price 36.29 USD Change: Unchanged 0.00 Percent change: Unchanged 0.00%

Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed

Expense ratio
0.61%
Prospectus 1 Mar 2026
Net assets
$170.6M
As of 31 Jul 2026
Holdings
195
As of 31 Jul 2026
12-month distribution yield
0.49%
Yearly
Asset class
Equity
From holdings

Harbor Human Capital Factor US Small Cap ETF (HAPS) is an exchange-traded fund listed on NYSE Arca in the United States, issued by Harbor. Its category is Equity · US (equity). Its last price was US$36.29 on 20 Oct 2026. Its expense ratio is 0.61% a year, from its prospectus dated 1 Mar 2026. It reported net assets of US$170.62 million as of 31 Jul 2026. Its latest holdings report lists 195 holdings as of 31 Jul 2026. Over the last 12 months it paid distributions of US$0.18 a unit, a 12-month distribution yield of 0.49%, paid yearly.

General information only: nothing on TakeProfits takes into account your objectives, financial situation or needs, and it isn't personal financial advice or a recommendation to buy or sell anything. Consider whether it suits you and get advice from a licensed adviser before acting. Market data may be delayed and comes from third-party sources.

Fees

Total annual operating expenses (gross)
0.61%
Net, after fee waivers or reimbursements
No waiver stated
Management fee
0.60%
Prospectus date
1 Mar 2026
Filed with the SEC
27 Feb 2026

Size and reporting

Net assets
$170,620,873
Total assets
$170,708,165
Holdings as of
31 Jul 2026
Report made public
25 Sep 2026 (56 days after the month end)

Net assets are for the whole fund series, which for some funds (Vanguard's, for example) also includes mutual fund share classes.

Top holdings

Largest 25 of 195 positions, as of 31 Jul 2026. Weight is the percent of net assets the fund reported.

HAPS top holdings as of 31 Jul 2026
# Holding Identifier Weight Value (USD) Type Country Currency
1 Twist Bioscience Corp US90184D1000 2.86% $4.9M Equity (common) United States USD
2 Kymera Therapeutics Inc US5015751044 2.21% $3.8M Equity (common) United States USD
3 Phillips Edison & Co Inc US71844V2016 1.97% $3.4M Equity (common) United States USD
4 Organon & Co US68622V1061 1.71% $2.9M Equity (common) United States USD
5 Magnolia Oil & Gas Corp US5596631094 1.64% $2.8M Equity (common) United States USD
6 Sensient Technologies Corp US81725T1007 1.62% $2.8M Equity (common) United States USD
7 Resideo Technologies Inc US76118Y1047 1.59% $2.7M Equity (common) United States USD
8 Avnet Inc US0538071038 1.59% $2.7M Equity (common) United States USD
9 Apple Hospitality REIT Inc US03784Y2000 1.49% $2.5M Equity (common) United States USD
10 Viasat Inc US92552V1008 1.37% $2.3M Equity (common) United States USD
11 GATX Corp US3614481030 1.31% $2.2M Equity (common) United States USD
12 Archrock Inc US03957W1062 1.26% $2.2M Equity (common) United States USD
13 Hancock Whitney Corp US4101201097 1.21% $2.1M Equity (common) United States USD
14 Chemours Co/The US1638511089 1.20% $2.1M Equity (common) United States USD
15 InvenTrust Properties Corp US46124J2015 1.19% $2.0M Equity (common) United States USD
16 Atlantic Union Bankshares Corp US04911A1079 1.14% $1.9M Equity (common) United States USD
17 Travel + Leisure Co US8941641024 1.13% $1.9M Equity (common) United States USD
18 Silicon Laboratories Inc US8269191024 1.12% $1.9M Equity (common) United States USD
19 Asbury Automotive Group Inc US0434361046 1.09% $1.9M Equity (common) United States USD
20 Powell Industries Inc US7391281067 1.07% $1.8M Equity (common) United States USD
21 Ultragenyx Pharmaceutical Inc US90400D1081 1.06% $1.8M Equity (common) United States USD
22 Piper Sandler Cos US7240782091 1.04% $1.8M Equity (common) United States USD
23 Tarsus Pharmaceuticals Inc US87650L1035 1.03% $1.7M Equity (common) United States USD
24 Granite Construction Inc US3873281071 0.98% $1.7M Equity (common) United States USD
25 AtriCure Inc US04963C2098 0.94% $1.6M Equity (common) United States USD

Breakdowns

Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.

Asset type

Asset type by weight
TypeWeightBar
Equity (common) 100.02%

Country

Country by weight
CountryWeightBar
United States 96.33%
Israel 0.99%
Panama 0.83%
Bermuda 0.72%
Ireland 0.62%
Luxembourg 0.32%
Guernsey 0.22%

Currency exposure

Currency exposure by weight
CurrencyWeightBar
US dollar (USD) 100.02%

Sector

Sector weights for holdings matched to listed stocks
SectorWeightBar
Finance 13.12%
Consumer Discretionary 11.02%
Technology 10.13%
Real Estate 6.85%
Health Care 6.25%
Industrials 5.87%
Utilities 3.81%
Energy 3.62%
Miscellaneous 0.67%
Telecommunications 0.61%
Consumer Staples 0.59%
Unknown 0.32%

Source: SEC Form N-PORT (opens in a new tab) Holdings as of

Distributions

Paid in the last 12 months
$0.1780
1 payment per unit
12-month yield
0.49%
Distributions only, not total return
Frequency
Yearly
From the gaps between ex-dates
Latest ex-date
19 Dec 2025

12-month yield = distributions per unit with an ex-date in the last 12 months ($0.1780) ÷ latest price ($36.29) × 100 = 0.49%. It looks back, so it is not a forecast; special distributions in the window are included.

Why a distribution yield is not the fund's return: yield vs total return

Distribution history table (3 payments)
HAPS distributions per unit by ex-date
Ex-dateAmount per unit
19 Dec 2025$0.1780
20 Dec 2024$0.2110
21 Dec 2023$0.1180

Filings and sources

Compare with

Largest funds in the same category:

Up to four symbols separated by commas. ASX funds end in .AX, for example IVV.AX.

How ETF overlap is measured, with a worked example

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.

Catalyst evidence

Loading…

Loading evidence…

Supporting sources

    Skip to main content

    All resources and tools

    Market ticker

    Markets

    Research

    Tools

    My investments

    Account

    Region and currency

    Colour theme